Establishment and verification of a risk assessment model for endoscopic treatment of gastrointestinal submucosal tumors based on endoscopic ultrasonography

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000040118

Enrollment

Unknown

Registered

2020-11-21

Start date

2020-12-01

Completion date

Unknown

Last updated

2021-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Submucosal tumors of the digestive tract

Interventions

Case series:Nil

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Inpatients aged 18 years and older undergoing EUS examination; (2) Patients agreed to participate in the study and be able to sign written informed consent; (3) Patients appropriate and agreed to undergo endoscopic treatment of submucosal tumors of the digestive tract.

Exclusion criteria

Exclusion criteria: (1) Patients with contraindications to endoscopic ultrasound; (2) Patients with contraindications to endoscopic treatment; (3) Patients who failed to complete endoscopic ultrasound or endoscopic treatment for special reasons.

Design outcomes

Primary

Measure	Time frame
Incidence of complications;Length of endoscopic treatment time;Cost;Clinical indicators (symptoms, signs, laboratory indicators);	—

Countries

China

Contacts

Public ContactNing Zhong

Department of Gastroenterology, Qilu Hospital, Cheloo College of Medicine, Shandong University

nathan.zhongning@foxmail.com+86 18560086096

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026